Exact Mass: 525.1552458
Exact Mass Matches: 525.1552458
Found 170 metabolites which its exact mass value is equals to given mass value 525.1552458
,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
N-(1-Cyanocyclopropyl)-4-fluoro-4-methyl-2-[[2,2,2-trifluoro-1-[4-(4-methylsulfonylphenyl)phenyl]ethyl]amino]pentanamide
O-Demethyl apixaban sulfate
9-Hydroxy-9-methoxycarbonyl-8-methyl-14-n-propoxy-2,3,9,10-tetrahydro-8,11-epoxy-1H,8H,11H-2,7b,11a-triazadibenzo(a,g)cycloocta(cde)trinden-1-one
(2S,3S,4R,4aS,6S,11bS)-1,2,3,4,5,6-hexahydro-3,4-dimethoxy-4a,11b-(epiminoethano)-4,6-epoxyphenanthro[2,3-d][1,3]dioxol-2-yl-3,4-dimethoxybenzoate|(6beta,7beta,8beta,10beta)-8,10-epoxy-7,8-dimethoxy-2,3-(methylenedioxy)hasubanan-6-yl-3,4-dimethoxybenzoate|hernsubanine B
Asn Asp Tyr Asp
C21H27N5O11 (525.1706992000001)
(glutathion-S-yl)-4-methoxy-3-indolylmethylisothiocyanate
AVE3247
C25H24ClN5O4S (525.1237454000001)
CONFIDENCE standard compound; INTERNAL_ID 601; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 4119; ORIGINAL_PRECURSOR_SCAN_NO 4117 CONFIDENCE standard compound; INTERNAL_ID 601; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 4131; ORIGINAL_PRECURSOR_SCAN_NO 4129 CONFIDENCE standard compound; INTERNAL_ID 601; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 4097; ORIGINAL_PRECURSOR_SCAN_NO 4095 CONFIDENCE standard compound; INTERNAL_ID 601; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 4123; ORIGINAL_PRECURSOR_SCAN_NO 4120 CONFIDENCE standard compound; INTERNAL_ID 601; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 4111; ORIGINAL_PRECURSOR_SCAN_NO 4110 CONFIDENCE standard compound; INTERNAL_ID 601; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 4113; ORIGINAL_PRECURSOR_SCAN_NO 4110 CONFIDENCE standard compound; INTERNAL_ID 601; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 8282; ORIGINAL_PRECURSOR_SCAN_NO 8277 CONFIDENCE standard compound; INTERNAL_ID 601; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 8287; ORIGINAL_PRECURSOR_SCAN_NO 8282 CONFIDENCE standard compound; INTERNAL_ID 601; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 8298; ORIGINAL_PRECURSOR_SCAN_NO 8293 CONFIDENCE standard compound; INTERNAL_ID 601; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 8344; ORIGINAL_PRECURSOR_SCAN_NO 8340 CONFIDENCE standard compound; INTERNAL_ID 601; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 8344; ORIGINAL_PRECURSOR_SCAN_NO 8342 CONFIDENCE standard compound; INTERNAL_ID 601; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 8341; ORIGINAL_PRECURSOR_SCAN_NO 8338
Ala Cys Phe Trp
Ala Cys Trp Phe
Ala Phe Cys Trp
Ala Phe Trp Cys
Ala Trp Cys Phe
Ala Trp Phe Cys
Cys Ala Phe Trp
Cys Ala Trp Phe
Cys Cys Asp Trp
Cys Cys Trp Asp
Cys Asp Cys Trp
Cys Asp Trp Cys
Cys Glu Phe Gln
Cys Glu Gln Phe
Cys Phe Ala Trp
Cys Phe Glu Gln
Cys Phe Gln Glu
Cys Phe Trp Ala
Cys Met Ser Trp
Cys Met Trp Ser
Cys Gln Glu Phe
Cys Gln Phe Glu
Cys Ser Met Trp
Cys Ser Trp Met
Cys Trp Ala Phe
Cys Trp Cys Asp
Cys Trp Asp Cys
Cys Trp Phe Ala
Cys Trp Met Ser
Cys Trp Ser Met
Asp Cys Cys Trp
Asp Cys Trp Cys
Asp Asp Asn Tyr
C21H27N5O11 (525.1706992000001)
Asp Asp Tyr Asn
C21H27N5O11 (525.1706992000001)
Asp Phe Met Asn
Asp Phe Asn Met
Asp Met Phe Asn
Asp Met Asn Phe
Asp Asn Asp Tyr
C21H27N5O11 (525.1706992000001)
Asp Asn Phe Met
Asp Asn Met Phe
Asp Asn Tyr Asp
C21H27N5O11 (525.1706992000001)
Asp Trp Cys Cys
Asp Tyr Asp Asn
C21H27N5O11 (525.1706992000001)
Asp Tyr Asn Asp
C21H27N5O11 (525.1706992000001)
Glu Cys Phe Gln
Glu Cys Gln Phe
Glu Phe Cys Gln
Glu Phe Gln Cys
Glu Gln Cys Phe
Glu Gln Phe Cys
Phe Ala Cys Trp
Phe Ala Trp Cys
Phe Cys Ala Trp
Phe Cys Glu Gln
Phe Cys Gln Glu
Phe Cys Trp Ala
Phe Asp Met Asn
Phe Asp Asn Met
Phe Glu Cys Gln
Phe Glu Gln Cys
Phe Met Asp Asn
Phe Met Asn Asp
Phe Asn Asp Met
Phe Asn Met Asp
Phe Gln Cys Glu
Phe Gln Glu Cys
Phe Trp Ala Cys
Phe Trp Cys Ala
Met Cys Ser Trp
Met Cys Trp Ser
Met Asp Phe Asn
Met Asp Asn Phe
Met Phe Asp Asn
Met Phe Asn Asp
Met Met Met Asn
Met Met Asn Met
Met Asn Asp Phe
Met Asn Phe Asp
Met Asn Met Met
Met Ser Cys Trp
Met Ser Trp Cys
Met Trp Cys Ser
Met Trp Ser Cys
Asn Asp Asp Tyr
C21H27N5O11 (525.1706992000001)
Asn Asp Phe Met
Asn Asp Met Phe
Asn Phe Asp Met
Asn Phe Met Asp
Asn Met Asp Phe
Asn Met Phe Asp
Asn Met Met Met
Asn Tyr Asp Asp
C21H27N5O11 (525.1706992000001)
Gln Cys Glu Phe
Gln Cys Phe Glu
Gln Glu Cys Phe
Gln Glu Phe Cys
Gln Phe Cys Glu
Gln Phe Glu Cys
Ser Cys Met Trp
Ser Cys Trp Met
Ser Met Cys Trp
Ser Met Trp Cys
Ser Trp Cys Met
Ser Trp Met Cys
Trp Ala Cys Phe
Trp Ala Phe Cys
Trp Cys Ala Phe
Trp Cys Cys Asp
Trp Cys Asp Cys
Trp Cys Phe Ala
Trp Cys Met Ser
Trp Cys Ser Met
Trp Asp Cys Cys
Trp Phe Ala Cys
Trp Phe Cys Ala
Trp Met Cys Ser
Trp Met Ser Cys
Trp Ser Cys Met
Trp Ser Met Cys
Tyr Asp Asp Asn
C21H27N5O11 (525.1706992000001)
Tyr Asp Asn Asp
C21H27N5O11 (525.1706992000001)
Tyr Asn Asp Asp
C21H27N5O11 (525.1706992000001)
4-Methylumbelliferyl 2-Acetamido-2-deoxy-4-O-(a-L-fucopyranosyl)-b-D-glucopyranoside
3-O-Methylfluorescein phosphate cyclohexylammonium salt
4-tert-Butyl-N-(6-chloro-5-(2-methoxyphenoxy)-2,2-bipyrimidin-4-yl)benzenesulfonamide
C25H24ClN5O4S (525.1237454000001)
odanacatib
C78281 - Agent Affecting Musculoskeletal System > C67439 - Bone Resorption Inhibitor C471 - Enzyme Inhibitor > C783 - Protease Inhibitor
4-Methylumbelliferyl 2-Acetamido-2-deoxy-3-O-(a-L-fucopyranosyl)-b-D-glucopyranoside
(1R)-2-[[6-[2-[(2,6-Dichlorobenzyl)oxy]ethoxy]hexyl]amino]-1-(2,2-dimethyl-4H-1,3-benzodioxin-6-yl)ethanol
CID 14392216
D004791 - Enzyme Inhibitors
1-Deoxy-5-O-Phosphono-1-(3,3,4,5-Tetramethyl-9,11-Dioxo-2,3,8,9,10,11-Hexahydro-7h-Quinolino[1,8-Fg]pteridin-12-Ium-7-Yl)-D-Ribitol
1-{[5-(5-chlorothiophen-2-yl)-1,2-oxazol-3-yl]methyl}-2-[(1-cyclopropylpiperidin-4-yl)carbamoyl]-1H-benzimidazole-5-carboxylic acid
C25H24ClN5O4S (525.1237454000001)
(4S,5E,6R)-4-[2-[2-(3,4-dihydroxyphenyl)ethoxy]-2-oxoethyl]-5-ethylidene-6-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-4H-pyran-3-carboxylate
(2S)-2-amino-5-[[(2R)-1-(carboxymethylamino)-3-[(4-methoxy-1H-indol-3-yl)methylcarbamothioylsulfanyl]-1-oxopropan-2-yl]amino]-5-oxopentanoic acid
2-[[(3,4-Dimethoxyphenyl)-oxomethyl]amino]acetic acid [2-[5-(4-chlorophenyl)-3-(2-furanyl)-3,4-dihydropyrazol-2-yl]-2-oxoethyl] ester
9-Hydroxy-9-methoxycarbonyl-8-methyl-14-n-propoxy-2,3,9,10-tetrahydro-8,11-epoxy-1H,8H,11H-2,7b,11a-triazadibenzo(a,g)cycloocta(cde)trinden-1-one
D004791 - Enzyme Inhibitors
(S)-JDQ-443
C29H28ClN7O (525.2043748000001)
(S)-JDQ-443 is an isomer of JDQ-443 (HY-139612). JDQ-443 is an orally active, potent, selective, and covalent KRAS G12C inhibitor (extracted from patent WO2021120890A1). JDQ-443 shows antitumor activity[1][2].
BMS-963272
C24H21F6N5O2 (525.1599358000001)
BMS-963272 is a potent, selective MGAT2 inhibitor (IC50 = 7.1 nM) for the research of metabolic disorders.
Opnurasib
C29H28ClN7O (525.2043748000001)
Opnurasib (JDQ-443) (NVP-JDQ443) is an orally active, potent, selective, and covalent KRAS G12C inhibitor (extracted from patent WO2021120890A1). Opnurasib shows antitumor activity[1][2].
1-[3-(3-{[1-carboxy-3-(c-hydroxycarbonimidoyl)propyl]carbamoyl}-6-hydroxy-9h-pyrido[3,4-b]indol-1-yl)propanoyl]pyrrolidine-2-carboxylic acid
C25H27N5O8 (525.1859542000001)
(2s)-1-{[(3r,3as,4s,9as,9bs)-9-(hydroxymethyl)-4-{[2-(4-hydroxyphenyl)acetyl]oxy}-6-methyl-2,7-dioxo-3h,3ah,4h,5h,9ah,9bh-azuleno[4,5-b]furan-3-yl]methyl}pyrrolidine-2-carboxylic acid
10-chloro-19-hydroxy-4,5,24-trimethyl-22-oxo-26,27-dioxa-7-azaheptacyclo[21.3.1.0¹,²⁰.0⁴,¹⁹.0⁵,¹⁶.0⁶,¹⁴.0⁸,¹³]heptacosa-6(14),8,10,12,20-pentaen-24-yl acetate
n-[(2s,3r,4r,6r)-16-hydroxy-3-methoxy-2-methyl-29-oxa-1,7,17-triazaoctacyclo[12.12.2.1²,⁶.0⁷,²⁸.0⁸,¹³.0¹⁵,¹⁹.0²⁰,²⁷.0²¹,²⁶]nonacosa-8(13),9,11,14(28),15(19),16,20(27),21(26),22,24-decaen-4-yl]-n-methylcarbamimidothioic acid
3-hydroxy-4,7,8-tris(1h-indol-3-yl)-1-oxaspiro[4.4]nona-3,7-diene-2,6,9-trione
3,4,5-trihydroxy-6-[(6-hydroxy-3-methyl-2-oxo-4,7-diphenyl-1,3-benzothiazol-5-yl)oxy]oxane-2-carboxylic acid
n-{16-hydroxy-3-methoxy-2-methyl-29-oxa-1,7,17-triazaoctacyclo[12.12.2.1²,⁶.0⁷,²⁸.0⁸,¹³.0¹⁵,¹⁹.0²⁰,²⁷.0²¹,²⁶]nonacosa-8(13),9,11,14(28),15(19),16,20(27),21(26),22,24-decaen-4-yl}-n-methylcarbamimidothioic acid
1-{[9-(hydroxymethyl)-4-{[2-(4-hydroxyphenyl)acetyl]oxy}-6-methyl-2,7-dioxo-3h,3ah,4h,5h,9ah,9bh-azuleno[4,5-b]furan-3-yl]methyl}pyrrolidine-2-carboxylic acid
(2s)-1-[3-(3-{[(1s)-1-carboxy-3-(c-hydroxycarbonimidoyl)propyl]carbamoyl}-6-hydroxy-9h-pyrido[3,4-b]indol-1-yl)propanoyl]pyrrolidine-2-carboxylic acid
C25H27N5O8 (525.1859542000001)